Champions Oncology (CSBR) Balance Sheet: Assets & Liabilities

Champions Oncology (CSBR) Balance Sheet

As of Apr 30, 2026 (end of fiscal 2026), Champions Oncology reported total assets of $26.99M and total liabilities of $22.92M. Shareholders' equity was $3.94M, up 4.4% from $3.77M a year earlier. Total debt stood at $4.51M against $4.87M in cash and short-term investments, a net cash position of $360.00K. That puts debt-to-equity at 1.15, compared with 1.62 a year earlier.

Champions Oncology Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Champions Oncology, Inc. (CSBR) - Annual data in millions USD
Breakdown	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Apr 2026	Apr 2025	Apr 2024	Apr 2023	Apr 2022	Apr 2021	Apr 2020	Apr 2019	Apr 2018	Apr 2017
Current Assets
Cash and Cash Equivalents	4.87	9.79	2.62	10.12	9.01	4.69	8.34	3.24	0.86	3.30
Cash & Short-Term Investments	4.87	9.79	2.62	10.12	9.01	4.69	8.34	3.24	0.86	3.30
Accounts Receivable	6.71	6.84	9.53	3.84	9.51	6.99	4.77	4.38	3.92	2.27
Inventory	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	1.17	1.37	1.50	1.33	1.14	0.96	0.39	0.31	0.29	0.30
Total Current Assets	19.22	22.36	13.64	19.46	19.66	12.63	13.50	7.92	5.06	5.87
Non-Current Assets
Property, Plant & Equipment (Net)	7.22	9.46	11.97	14.50	15.36	14.61	6.79	2.55	2.08	1.22
Long-Term Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.15	-21.82
Goodwill	0.34	0.34	0.34	0.34	0.34	0.34	0.34	0.67	0.67	0.67
Other Non-Current Assets	0.21	0.20	0.19	0.02	0.02	0.02	0.13	0.13	0.27	0.26
Total Non-Current Assets	7.77	9.99	12.49	14.85	15.71	14.96	7.25	3.34	3.02	2.14
Total Assets	26.99	32.34	26.13	34.31	35.38	27.59	20.75	11.27	8.08	8.01
Current Liabilities
Accounts Payable	6.90	4.25	5.80	5.33	2.87	1.89	3.14	2.81	2.15	1.85
Short-Term Debt	1.52	1.47	1.34	1.21	1.05	0.82	0.63	0.02	0.03	0.03
Accrued Liabilities	2.59	2.56	2.16	2.27	2.41	2.23	-	-	-	-
Deferred Revenue	8.83	15.44	12.09	12.78	11.07	6.26	5.82	4.02	4.70	4.91
Other Current Liabilities	0.08	0.14	0.15	0.15	0.07	2.23	2.70	1.18	0.60	0.66
Total Current Liabilities	19.92	23.85	21.54	21.73	17.48	11.20	12.30	8.03	7.48	7.45
Non-Current Liabilities
Long-Term Debt	2.99	4.63	6.09	7.39	8.41	8.78	3.17	0.00	0.02	0.00
Other Non-Current Liabilities	0.01	0.09	0.40	0.55	0.39	0.18	0.18	1.00	0.60	0.16
Total Non-Current Liabilities	3.00	4.72	6.49	7.94	8.80	8.96	3.35	1.00	0.62	0.16
Total Liabilities	22.92	28.57	28.04	29.68	26.28	20.16	15.65	9.03	8.10	7.61
Stockholders' Equity
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Retained Earnings	-81.07	-79.89	-84.59	-77.32	-71.98	-72.53	-72.89	-70.70	-70.83	-69.35
Treasury Stock	0.71	0.71	0.71	0.07	-	-	-	-	-	-
Additional Paid-in Capital	85.70	84.36	82.68	82.01	81.06	79.95	77.98	72.92	70.82	69.74
Minority Interest	0.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Shares Outstanding	13.89	13.78	13.59	13.54	13.52	-	-	-	-	-
Total Stockholders' Equity	3.94	3.77	-1.90	4.64	9.10	7.43	5.10	2.24	0.00	0.40
Total Liabilities & Equity	26.99	32.34	26.13	34.31	35.38	27.59	20.75	11.27	8.08	8.01

Source: Company financial statements from annual and quarterly filings. Data as of Jul 31, 2026. Data sources and methodology

Frequently Asked Questions About Champions Oncology Balance Sheet

How much debt does Champions Oncology have?

Champions Oncology had total debt of $4.51M as of Apr 30, 2026, against $4.87M in cash and short-term investments. Its debt-to-equity ratio was 1.15. Total debt was $6.11M a year earlier.

What are Champions Oncology's total assets?

Champions Oncology reported total assets of $26.99M as of Apr 30, 2026, down 16.6% from $32.34M a year earlier. Total liabilities were $22.92M.

What is Champions Oncology's shareholders' equity?

Champions Oncology's shareholders' equity was $3.94M as of Apr 30, 2026, or about $0.28 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition